Results 71 to 80 of about 276,371 (290)

NPC‐0501 trial on the value of changing chemoradiotherapy sequence, replacing 5‐fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma

open access: yesCancer, 2020
A current recommendation for the treatment of patients with locoregionally advanced nasopharyngeal carcinoma (NPC) is conventional fractionated radiotherapy (RT) with concurrent cisplatin followed by adjuvant cisplatin and 5‐fluorouracil (PF).
Anne W. M. Lee   +13 more
semanticscholar   +1 more source

Paralytic Ileus- A Rare but Serious Side-effect of Oral Capecitabine

open access: yesInternational Journal of Anatomy Radiology and Surgery, 2022
Paralytic ileus is a condition where the intestine becomes paralysed in the absence of any mechanical obstruction. The common causes are intra-abdominal surgery, severe metabolic problems and drugs.
Rahul Roy, Subhadip Sarkar
doaj   +1 more source

Comparison of the efficacy of microneedling combined with 5-fluorouracil 5% cream versus microneedling combined with tacrolimus 0.1% ointment in the treatment of vitiligo

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Background and Design: Vitiligo is an acquired depigmenting disorder associated with profound psychological effects. It can manifest as depigmented macules that can be localized or generalized in nature.
Parwaaz Matharoo   +3 more
doaj   +1 more source

Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]

open access: yes, 2019
Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core  

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments. [PDF]

open access: yes, 2018
In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of ...
Alifrangis, C   +11 more
core   +2 more sources

Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.

open access: yesJournal of Clinical Oncology, 2012
PURPOSE Treatment for metastatic colorectal cancer (mCRC) commonly involves a fluoropyrimidine-based chemotherapy regimen such as infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) or fluorouracil, leucovorin, and oxaliplatin, often combined ...
E. Van Cutsem   +14 more
semanticscholar   +1 more source

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma.

open access: yesNew England Journal of Medicine, 1990
Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive (Stage B2) or had regional nodal involvement (Stage C) were randomly assigned to observation or to treatment for one year with levamisole combined with ...
C. Moertel   +11 more
semanticscholar   +1 more source

Duration of adjuvant chemotherapy for stage III colon cancer [PDF]

open access: yes, 2018
BACKGROUND Since 2004, a regimen of 6 months of treatment with oxaliplatin plus a fluoropyrimidine has been standard adjuvant therapy in patients with stage III colon cancer.
Andre, Thierry   +22 more
core   +1 more source

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

open access: yesNew England Journal of Medicine, 2007
BACKGROUND Phase 2 studies suggest that the standard regimen of cisplatin and fluorouracil (PF) plus docetaxel (TPF) improves outcomes in squamous-cell carcinoma of the head and neck.
J. Vermorken   +17 more
semanticscholar   +1 more source

A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803. [PDF]

open access: yes, 2017
PurposeTumor levels of thymidylate synthase (TS), a target of 5-fluorouracil (5-FU)-based chemotherapy for colorectal cancer, have been studied as a predictive or prognostic biomarker with mixed results.Patients and methodsTumor TS levels were ...
Bertagnolli, Monica M   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy